Back to R2 link
Top Industry News
- MHRA - Implementation of Medical Devices Future Regime
- Notice from MFDS Regarding Partial Amendment of Standards for Unfair Labeling or Advertising of Food, and Related Matters
- Swissmedic - Changes to the Guidance Document Fast-Track Authorisation Procedure
- MHRA - Regulatory Roadmap Points the way Ahead for New Measures to Support Safe Access to Medical Technology Including AI and Diagnostics
- MHRA Guidance on Labelling and Packaging of Medicinal Products for Human use Following Agreement of the Windsor Framework
- FDA Guidance on Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin
- MFDS released a Notification of Re-designation of Imported Food Subject to Inspection Order
- FDA Guidance on Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile
- Swissmedic - Changes to Guidance Document Authorisation of Human Medicinal Product with Known Active Pharmaceutical Ingredient
- SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation - 12th revision: Corrigendum Adopted on 21 December 2023
- Canada | In-Depth Overview of Health Canada's Latest Regulations Regarding Cosmetic Animal Testing
- Swissmedic - Changes to the Guidance Document Authorisation of Human Medicinal Products Under Art. 13 TPA
- Notice of Proposal from Health Canada for the Revision of Nutrition Labelling: Reference Amounts for Food Table (NOP/ADP-QRA-2023-2)
- MHRA Guidance on Exporting Active Substances Manufactured in Great Britain for use in EEA and Northern Ireland
- FDA Guidance on Requests for Reconsideration at the Division Level Under GDUFA
- Regulation 2024/20 by the European Commission: Non-Renewal of Approval for S-metolachlor Due to Environmental and Health Concerns
- MHRA Guidance on Register Medical Devices to Place on the Market